← Back to Clinical Trials
Recruiting NCT06966674
No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track
Trial Parameters
Condition No-Reflow
Sponsor Kafrelsheikh University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-05-12
Completion 2025-10-01
All Conditions
Interventions
Intracoronary tirofibanSaline 0.9%
Brief Summary
This study aims to assess the no-reflow in patients with STEMI after intracoronary glycoprotein IIb/IIIa inhibitors after opening of track in thrombus.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years old. * Both sexes. * Patients with STEMI. ST-segment elevated myocardial infarction is defined as typical chest pain \>30 minutes with ST-segment elevation of \>1 mm in at least 2 consecutive leads on the electrocardiogram or new-onset left bundle brunch block. Exclusion Criteria: * Treatment with thrombolytic drugs in the previous 24 hours. * Known malignancy. * Thrombocytopenia. * End-stage liver disease. * Cardiogenic shock. * Renal failure with glomerular filtration\<30 ml/min. * Contraindication for the use of tirofiban.